Page 3 - Shimadzu Journal vol.3 Issue3

Dear Reader,

I am Shuzo Maruyama, the new General Manager of the Analytical and Measuring
Instruments Division. I replace Teruhisa Ueda, who was promoted to President and
Chief Executive Officer this past June.
Prior to this position, I spent three years and a half as president of Shimadzu
Scientific Instruments, Inc., the U.S. subsidiary of Shimadzu Corporation. During my
presidency there, I experienced many collaborations, the biggest of which was the
agreement with the University of Texas at Arlington. A more recent one is with the
Milwaukee Institute for Drug Discovery, which we introduce in this issue. Those
experiences have convinced me that only collaborative works with customers can
advance new technologies that will bring the true solutions to the world.
Recently, we established two innovation centers. One is at our U.S. headquarters in
Columbia, Maryland to develop close collaborations with universities, government
agencies, and industry centers in order to capitalize on the cutting-edge research
being conducted in and around the area. The Baltimore-Washington, DC area is
home to many research institutes in the fields of clinical research and health care,
such as the National Institutes of Health, its affiliated National Cancer Institute, and
Johns Hopkins University. We plan to utilize this geographic location to the fullest
in order to develop solutions with customers. The other is the Shimadzu China
Mass Spectrometry Center at the Beijing Branch of Shimadzu (China) Co., Ltd., a
Shimadzu subsidiary in China. This center’s purpose will be to increase Shimadzu’s
share of the mass spectrometry market and to promote cutting-edge joint research
and development in China. We will be opening other innovation centers worldwide
for the same purpose in the near future.

Shimadzu Journal has featured various collaborative research projects in specific
application fields since its launch in October 2013. This issue focuses on
pharmaceuticals. One of the featured articles is about the collaboration with
Associate Professor Alexander Arnold from the Milwaukee Institute for Drug
Discovery at the University of Wisconsin-Milwaukee, mentioned above, while
another article discusses a collaboration with Mitsubishi Tanabe Pharma
Corporation, Japan. In addition, this issue contains information on other applicable
topics, as well as the latest news and applications.
th
Lastly, the year 2015 marks Shimadzu’s 140 anniversary. Our long history is a
testament to the relationships we’ve built with customers throughout the world
who utilize our technologies and solutions to meet their needs. Guided by our
corporate philosophy: “Contributing to Society through Science and Technologies”
and this year’s slogan: “Design the future”, we will strive to fulfill customers’
wishes more than ever. We are motivated by the depth of future opportunities, and
it’s our sincere desire to exceed expectations and establish high-quality customer
relationships.
We hope that you and Shimadzu build new era together, hand in hand, and that
this journal will be of great help to all of you. We always welcome your feedback.

Yours Sincerely,

Shuzo Maruyama

&
Analytical
General Manager, Analytical & Measurement Instruments Division
General
Manager